Growth Metrics

Zymeworks (ZYME) Net Margin (2021 - 2026)

Zymeworks recorded quarterly Net Margin of 1833.97% in Q1 2026, down 11.93% quarter-over-quarter from 1638.53% in Q4 2025, and down 110378.0% year-over-year from N/an in Q1 2025.

Zymeworks' Net Margin history runs 6 years deep, the most recent figure standing at 1833.97% for Q1 2026.

  • In Q1 2026, Net Margin fell 110378.0% year-over-year to 1833.97%; the TTM figure through Mar 2026 stood at 130.52% (up 6503.0% YoY), while the FY2025 annual figure was 76.56%, up 8423.0% from the prior year.
  • Net Margin came in at 1833.97% for Q1 2026 at Zymeworks, down from 1638.53% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 95.21% in Q4 2022 to a low of 3790.45% in Q1 2022.
  • A 5-year average of 769.7% and a median of 315.58% in 2024 frame the typical range for Net Margin.
  • Across the five-year window, Net Margin soared 372200 bps in 2023 and sank 156278 bps in 2025, its largest moves.
  • Zymeworks' Net Margin stood at 95.21% in 2022, then plunged by 190 bps to 85.56% in 2023, then climbed by 11 bps to 75.75% in 2024, then slumped by 2063 bps to 1638.53% in 2025, then declined by 12 bps to 1833.97% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 1833.97%, 1638.53%, and 78.41% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.82%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 34.53%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 20.17%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 17.65%
10 Zymeworks 1.84 Bn 1.47 Bn - -1,833.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,833.97%
Dec 31, 2025 -1,638.53%
Sep 30, 2025 -78.41%
Jun 30, 2025 4.76%
Mar 31, 2025 -730.19%
Dec 31, 2024 -75.75%
Sep 30, 2024 -186.56%
Jun 30, 2024 -471.08%
Mar 31, 2024 -315.58%
Dec 31, 2023 -85.56%
Sep 30, 2023 -173.80%
Jun 30, 2023 -730.53%
Mar 31, 2023 -68.45%
Dec 31, 2022 95.21%
Sep 30, 2022 -1,818.55%
Jun 30, 2022 -1,187.41%
Mar 31, 2022 -3,790.45%
Dec 31, 2021 -489.40%
Sep 30, 2021 -1,378.36%